February 9, 2018
Is it nature or nurture that ultimately shapes a human? Are actions and behaviors a result of genes or environment?
Variations of these questions have been explored by countless philosophers and scientists across millennia.
Yet, as biologists continue to better understand the mechanisms that underlie brain function, it is increasingly apparent that this long-debated dichotomy may be no dichotomy at all.
January 12, 2018
Boston Globe (January 2, 2018): Dementia Patients Often Need Hospitals, Which are Often Ill-Prepared
Steve Johanson had a fierce and knowledgeable advocate at his side when he visited a hospital recently: his wife, Judy. In the six years since Steve had been diagnosed with early-onset Alzheimer’s disease, she had immersed herself in understanding the illness and preparing for its consequences.
But even so, the hospital stay to adjust Steve’s Alzheimer’s medication was a nightmare. In the emergency room, nurses briskly took his vital signs, oblivious to his confusion. When he became upset, the staff didn’t seem to understand why.
January 12, 2018
Harvard Gazette (January 11, 2018): Harvard Researchers to Help Develop Cloud-Based NIH Data Commons Platform
The National Institute of Health has announced that Harvard co-Principal Investigators Dr. Mercè Crosas and Dr. Timothy Clark are NIH Data Commons Pilot Phase Awardees.
December 13, 2017
CONGRATULATIONS TO DR. ANN MCKEE -- OUR FORMER NEUROPATHOLOGY FELLOW!
AT A SHOE DEALER CONVENTION in Boston in 1920, Dr. Jacob Lowe showed off an invention he called the Foot-O-Scope. His fluoroscope used an X-ray tube to produce a fluorescent image of the bones in a foot as well as the shoe around it, ensuring a perfect fit. It was a modification of a device the Boston physician created during World War I to examine the injured feet of servicemen without removing their boots.
December 11, 2017
EurekAlert (December 11, 2017): Up to $70 Million to be Awarded to Advance Alzheimer's Disease Clinical Trials
The National Institutes of Health (NIH) is expected to award up to $70 million over five years to three physician-scientists to launch the Alzheimer's Clinical Trials Consortium (ACTC), which will create a network of 35 Alzheimer's disease trial sites across the country with the goal of finding new ways to treat or prevent Alzheimer's.
December 8, 2017
MGH NeuroBlast (December 4, 2017): Massachusetts General Hospital's NPH Program Offers Comprehensive Evaluation & Treatment of Brain Disorder
At 79, Tamar wasn’t ready to slow down: She walked three miles a day, was a whiz at Sudoku puzzles, and loved hiking with her husband. But within just a year, she had sharply declined. The once-vibrant septuagenarian could no longer get out of a chair unassisted, didn’t understand how to use a telephone, and had become incontinent. “She was a shell of her former self,” remembers her daughter Iris. “Her physician told us that she had atypical Alzheimer’s disease and that nothing could be done for her.”
November 28, 2017
MGH Research Institute (November 28, 2017): Gatchel Untangles the Causes of Mood & Anxiety Symptoms & Loss of Brain Function in Aging Populations
Often referred to as the golden years, life after retirement can sometimes turn out to be less than sunny.
Dramatic lifestyle changes such as admittance to an assisted care facility and loss of mobility or independence can take a toll on mental health.
In fact, twenty percent of people over 55 suffer from a mental disorder, and two-thirds of nursing home residents exhibit mental and behavioral problems.
November 21, 2017
Holidays can be meaningful, enriching times for both the person with Alzheimer’s disease and his or her family. Maintaining or adapting family rituals and traditions helps all family members feel a sense of belonging and family identity. For a person with Alzheimer’s, this link with a familiar past is reassuring.
November 13, 2017
Washington Post (November 13, 2017): Bill Gates Joins the Fight Against Alzheimer’s — and It’s Personal
Billionaire Bill Gates is personally investing $50 million to help fund research to find a treatment for Alzheimer’s disease, a type of dementia that Gates says has struck members of his own family.
There is no cure for Alzheimer’s, which destroys memory and other mental processes, and so Gates said he is investing his own money into the Dementia Discovery Fund, a private-public partnership to search for a solution.
November 8, 2017
Alzheimer's Association (November 6, 2017): The Building Our Largest Dementia (BOLD) Infrastructure Act introduced in House & Senate
The Alzheimer’s Association and the Alzheimer’s Impact Movement (AIM) are proud to support the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act, new bipartisan legislation prioritizing our nation’s approach to Alzheimer’s disease. The BOLD Infrastructure for Alzheimer’s Act was introduced by Senators Susan Collins (R-Maine), Catherine Cortez Masto (D-Nev.), Shelley Moore Capito (R-W.Va.), Tim Kaine (D-Va.), and by Representatives Brett Guthrie (R-Ky.), Paul Tonko (D-N.Y.), Chris Smith (R-N.J.) and Maxine Waters (D-Calif.).